Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × roniciclib × Clear all

NCT02522910 2016-08-10

An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung